First Citizens BancShares Inc., through its division Silicon Valley Bank, has released its 2025 Healthtech market analysis, highlighting a surge in venture capital investment in provider operations. According to the report, provider operations-covering activities such as scheduling, documentation, and billing-have attracted $5.5 billion in investment so far this year, with projections reaching $8.25 billion by year-end. This sub-sector now accounts for 44% of overall Healthtech investment, on track to surpass previous records. AI-enabled solutions dominate the sector, comprising 73% of Healthtech mega-deals and 52% of all deals in 2025. The report also notes a 42% increase in seed-stage AI valuations since 2021 and a notable rise in consolidation, with 32 M&A deals recorded in provider operations this year. Generalist investors like Andreessen Horowitz and General Catalyst are driving a 22% valuation premium in mega-deals, which make up 38% of total Healthtech investment. Overall, Healthtech investment is expected to reach $18.5 billion by the end of 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Citizens BancShares Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF99485) on October 16, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.